DCVC | Activity | F4

Team Portfolio Raise Essays

F4/DCVC/Activity

DCVC Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Milestone

Portfolio company Radiant received a $750 million U.S. Army award for advanced nuclear microreactor development.

Radiant

dcvc.comAUG 26, 2026

AUG 26, 2026

Investment

DCVC co-led Emerald AI's $150 million Series A round to transform data centers into intelligent grid-responsive assets.

Emerald AI

Emerald AI DCVC

dcvc.comAUG 25, 2026

AUG 25, 2026

Investment

DCVC joined a $100 million seed round for Callosum, which is building a new orchestration layer for heterogeneous AI.

Callosum

dcvc.comAUG 20, 2026

AUG 20, 2026

Milestone

Portfolio company Relation announced a strategic collaboration with GSK for its MORGAN cellular foundation model, worth up to $110 million in upfront and milestone payments.

Relation

RelationDCVC

dcvc.comJUL 30, 2026

JUL 30, 2026

Essay

DCVC published its fourth annual Deep Tech Opportunities Report, themed 'Back to Fundamentals in an Age of Exponential Change', covering energy, AI, quantum, manufacturing, drug discovery, robotics, and defense.

2026 Deep Tech Opportunities Report

dcvc.comJUL 1, 2026

JUL 1, 2026

New Fund

DCVC is raising $1.3 billion across its flagship seventh fund and a second energy and climate fund, riding the momentum of the Fervo Energy IPO.

DCVC raising $1.3B across flagship fund VII and second energy/climate fund

axios.comJUN 16, 2026

JUN 16, 2026

Milestone

Atom Computing was included in a U.S. Department of Commerce quantum investment program, including a $100M equity stake.

Atom Computing

Atom Computing DCVC

dcvc.comMAY 21, 2026

MAY 21, 2026

Exit

Portfolio company Fervo Energy completed its IPO on Nasdaq under ticker FRVO.

Fervo Energy

Fervo EnergyDCVC

dcvc.comMAY 13, 2026

MAY 13, 2026

Investment

Co-led Quantum Motion's $160M Series C to scale silicon-spin quantum computing.

Quantum Motion

Quantum Motion DCVC

dcvc.comMAY 7, 2026

MAY 7, 2026

Investment

Co-led Kanvas Biosciences' $48M Series A for microbiome therapeutics.

Kanvas Biosciences

Kanvas Biosciences DCVC

dcvc.comMAY 6, 2026

MAY 6, 2026

Essay

Published a defense and space thesis highlighting portfolio companies across launch, orbital logistics, earth observation, and drone defense.

Startup-built technologies are bringing new ways to dominate in the air and in space

dcvc.comMAY 4, 2026

MAY 4, 2026

Essay

Published a DCVC Bio thesis on protein-like polymers for intracellular drug delivery.

There is an exciting new way to put protein-like drugs inside cells

dcvc.comAPR 27, 2026

APR 27, 2026

Exit

Portfolio company Horizon Quantum Computing exited.

Horizon Quantum Computing

Horizon Quantum ComputingDCVC

cbinsights.comMAR 2026

MAR 2026

Investment

Led Proxima's $80M seed round for protein reprogramming therapeutics.

Proxima

linkedin.comJAN 2026

JAN 2026

Page 1 of 2